6541 — Tanvex Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Tanvex Biopharma, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,069	2,226	786	381	377
Net Total Accounts Receivable
Net Total Receivables	1.91	0.36	2.76	10.4	0.939
Total Inventory
Prepaid Expenses
Total Current Assets	2,264	2,402	1,044	604	676
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,906	2,114	2,151	1,928	1,827
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	4,373	4,714	3,420	2,763	2,735
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	353	249	303	364	348
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,752	1,919	2,028	1,942	1,842
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2,621	2,795	1,391	821	893
Total Liabilities & Shareholders' Equity	4,373	4,714	3,420	2,763	2,735
Total Common Shares Outstanding